AI-guided precision fermentation platform producing cannabinoids, terpenes, tryptamines, rare alkaloids, and food ingredients via yeast.
CB Therapeutics is a precision synthetic biology company that uses an AI-guided, closed-loop design-build-test-learn process to engineer yeast for the scalable fermentation-based production of high-value compounds. The platform covers eight compound classes: phytocannabinoids (CBD, CBG, CBN, THCV), cannabinoid analogs, terpenes, tryptamines, tryptamine analogs, rare alkaloids (mitragynine, ergolines), animal-free proteins/fats, and novel food additives. The company holds eight US patents and has explored 100+ compounds over 12 years, partnering with pharma, wellness, and food-tech companies. CB Therapeutics is a product of CB Therapeutics.